The Joint Pharmaceutical Analysis Group of the Royal Society of Chemistry (JPAG) and The Academy of Pharmaceutical Sciences (APS) are pleased to announce a one-day meeting focussed on the challenges associated with oligonucleotide drug development.
There will be a full and exciting programme purposefully designed to facilitate access for delegates and speakers to a wide range of scientists, many of whom are leaders in their fields. The meeting seeks to provide a clear insight into challenges, strategies and opportunities of oligonucleotides processing from the perspective of analytics and materials science. It is intended to cover all stages of the product life cycle from development through to transfer challenges.
These knowledge sharing presentations will be delivered by highly regarded and experienced speakers across industry and academia. Ultimately, the meeting will provide unique attendee networking opportunities and a means of sharing real experiences with other professionals.
Dr Ken Cook - Thermo Fisher Scientific
Dr Thomas Halbritter - Eurofins
Prof Geoff Smith - De Montfort University
Maire Welham - AstraZeneca
Samuel Whitmarsh - CatSci
EVENT LINK: https://www.jpag.org/165
VENUE LINK: www.rsc.org/locations-contacts/
ORGANISED BY: Joint Pharmaceutical Analysis Group
WEB LINK: https://www.jpag.org/
SPONSORS: Royal Pharmaceutical Society and Royal Society of Chemistry
CONTACT: Hon Events Secretary JPAG, firstname.lastname@example.org